Displaying results 73 - 84 of 198
Metabolism, Alcohol & Toxicity
1

Closing of the event - NAFLD Summit 2022

View
Metabolism, Alcohol & Toxicity
6

Novo Nordisk:Clinical harmonisation for improving NASH diagnosis - NAFLD Summit 2022

View
Metabolism, Alcohol & Toxicity
6

Novo Nordisk:Clinical harmonisation for improving NASH diagnosis - NAFLD Summit 2022

View
Metabolism, Alcohol & Toxicity
6

Novo Nordisk:Clinical harmonisation for improving NASH diagnosis - NAFLD Summit 2022

View
Metabolism, Alcohol & Toxicity
6

Novo Nordisk:Clinical harmonisation for improving NASH diagnosis - NAFLD Summit 2022

View
Metabolism, Alcohol & Toxicity
6

Novo Nordisk:Clinical harmonisation for improving NASH diagnosis - NAFLD Summit 2022

View
Metabolism, Alcohol & Toxicity
6

Novo Nordisk:Clinical harmonisation for improving NASH diagnosis - NAFLD Summit 2022

View
General Hepatology
4

Patients/Nurses/European regulatory agencies - EASL Monothematic Conference - Bleeding, Thrombosis, and Vascular Liver Diseases 2021

View
General Hepatology
4

Patients/Nurses/European regulatory agencies - EASL Monothematic Conference - Bleeding, Thrombosis, and Vascular Liver Diseases 2021

View
General Hepatology
4

Patients/Nurses/European regulatory agencies - EASL Monothematic Conference - Bleeding, Thrombosis, and Vascular Liver Diseases 2021

View
General Hepatology
4

Patients/Nurses/European regulatory agencies - EASL Monothematic Conference - Bleeding, Thrombosis, and Vascular Liver Diseases 2021

View
Liver Tumours
4

Blast oral communications: Basic and translational research - Liver Cancer Summit 2022

View